The World Health Organization (WHO) has classified EG.5, which has been dubbed Eris, as a “variant of interest,” indicating that it should be watched more closely than others for mutations that could make it more contagious. or severe. Still, the WHO insists that at this time it does not appear to pose a greater threat to public health than other variants and that “there is no evidence of a directly associated increase in disease severity.”
EG.5 has been found in more than 50 countries as of August 8, according to the WHO. It is the most common covid-19 subvariant and is estimated to be responsible for around 17% of current cases. Among the symptoms of Eris are a sore throat, congestion, sneezing, cough or headache, which can easily be confused with a common cold.
Pfizer/BioNTech SE, Moderna, and Novavax have created new versions of their updated vaccines to target another Omicron sublineage, XBB.1.5, better known as Kraken. Eris would be similar to this, although the newer subvariant carries a mutation in its spike protein, the part of the virus that the vaccine targets.
The amount of virus identified in wastewater from the United States and the United Kingdom has increased significantly in the last month, which “gives clues” as to how the incidence could increase these weeks, according to the expert from the Andalusian School of Public Health, Joan Carlos March.
2023-08-21 21:38:54
#Eris #subvariant #Omicron #symptoms #recognize
